In a report released today, Richard Close from Canaccord Genuity initiated coverage with a Buy rating on Oak Street Health (OSH) and a price target of $67.00. The company’s shares closed last Tuesday at $57.17.
According to TipRanks.com, Close is a 5-star analyst with an average return of 32.9% and a 64.5% success rate. Close covers the Technology sector, focusing on stocks such as Castlight Health, Health Catalyst, and HealthStream.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Oak Street Health with a $68.60 average price target, representing a 18.8% upside. In a report issued on February 12, Morgan Stanley also maintained a Buy rating on the stock with a $73.00 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $66.31 and a one-year low of $34.98. Currently, Oak Street Health has an average volume of 682.3K.
Based on the recent corporate insider activity of 32 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of OSH in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Oak Street Health Inc is a fast-growing network of value-based, primary care centers for adults on Medicare. The company operates an healthcare model focused on quality of care over volume of services, and assumes the full financial risk of its patients. Oak Street Health operates more than 50 centers across Illinois, Michigan, Indiana, Pennsylvania, Ohio, Rhode Island, North Carolina and Tennessee, with plans to continue its geographic expansion, including into Texas and New York.
